OrthoPediatrics (NASDAQ:KIDS) Stock Price Down 3.5% on Insider Selling

OrthoPediatrics Corp. (NASDAQ:KIDS)’s stock price dropped 3.5% on Wednesday following insider selling activity. The stock traded as low as $24.48 and last traded at $24.54. Approximately 22,235 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 162,242 shares. The stock had previously closed at $25.42.

Specifically, insider Gregory A. Odle sold 5,359 shares of the firm’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $133,224.74. Following the completion of the transaction, the insider now directly owns 148,788 shares of the company’s stock, valued at $3,698,869.68. This trade represents a 3.48 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Fred Hite sold 6,443 shares of the firm’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $160,172.98. Following the completion of the transaction, the chief financial officer now directly owns 207,989 shares of the company’s stock, valued at approximately $5,170,606.54. The trade was a 3.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In other news, CEO David R. Bailey sold 6,620 shares of OrthoPediatrics stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $164,573.20. Following the completion of the sale, the chief executive officer now directly owns 319,155 shares of the company’s stock, valued at approximately $7,934,193.30. The trade was a 2.03 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on KIDS. Truist Financial dropped their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Stifel Nicolaus dropped their price objective on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a report on Wednesday, March 5th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a report on Wednesday, March 5th.

OrthoPediatrics Stock Performance

The company has a market cap of $596.44 million, a PE ratio of -19.95 and a beta of 1.22. The business’s 50-day moving average is $24.79 and its 200 day moving average is $25.53. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

OrthoPediatrics (NASDAQ:KIDS) last issued its earnings results on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.04. The company had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same quarter last year, the company earned ($0.23) EPS. On average, equities research analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Hedge Funds Weigh In On OrthoPediatrics

A number of hedge funds have recently modified their holdings of the company. AWM Investment Company Inc. increased its position in shares of OrthoPediatrics by 14.8% in the fourth quarter. AWM Investment Company Inc. now owns 516,794 shares of the company’s stock valued at $11,979,000 after acquiring an additional 66,779 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of OrthoPediatrics by 76.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 19,863 shares of the company’s stock valued at $460,000 after acquiring an additional 8,631 shares during the period. Point72 Asset Management L.P. purchased a new position in shares of OrthoPediatrics during the fourth quarter valued at about $7,450,000. Numerai GP LLC purchased a new position in shares of OrthoPediatrics during the fourth quarter valued at about $372,000. Finally, OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in OrthoPediatrics by 25.5% during the fourth quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 65,292 shares of the company’s stock worth $1,513,000 after acquiring an additional 13,270 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.